Displaying 1 to 17 of 17 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
AirXpanders A medical device company that has developed the AeroForm tissue expander. |
United States | 1 Mar 2011 | Venture Initial investment. Round participant. Active |
|
|
|
Avanir Pharmaceuticals Inc A biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. |
United States | 1 Jun 2012 | Debt Initial investment. Round participant. Active |
|
|
|
Ceptaris Therapeutics Inc Specialty pharmaceuticals company. |
United States | 1 Feb 2012 | Debt Initial investment. Round participant. Active |
|
|
|
Endocyte Inc Folate-based cancer and autoimmune disease therapies |
United States | N/A Initial investment. Round participant. Active |
||
|
|
EUSA Pharma Inc Trans-Atlantic specialty pharmaceutical company which focuses on oncology and critical care |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Innovative Spinal Technologies Inc Spine technology company. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Intuity Medical Inc |
United States | 1 Feb 2011 | N/A Initial investment. Round participant. Active |
|
|
|
MediciNova Inc Focuses on acquiring and developing novel, small-molecule therapeutics for the US market. |
United States | 1 May 2010 | Debt Initial investment. Round participant. Active |
|
|
NanoString Technologies Inc A life sciences company, markets solutions for detecting and counting large sets of target molecules in biological samples for researchers. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
NeoVista Inc |
United States | 1 Mar 2011 | Debt Initial investment. Round participant. Active |
|
|
|
SkinMedica Inc Engages developing, acquiring, and commercializing prescription and non-prescription skin care products that improve the appearance of skin. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
TearScience Inc Developer of a diagnostic and treatment devices targeted at the root cause of the majority of dry eye cases. |
United States | 1 Oct 2011 | Debt Active |
|
|
|
Tengion Inc A leading regenerative medicine company. |
United States | 1 Oct 2007 | Series C Initial investment. Round participant. Active |
|
|
|
Tethys Bioscience Inc |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Tranzyme Pharma Drug discovery and development, focused on gastroenterology indications |
United States | 1 Feb 2012 | Debt Initial investment. Round participant. Active |
|
|
|
Vitae Pharmaceuticals Inc Drug discovery company developing optimized drugs using proprietary computational drug design platform. |
United States | N/A Initial investment. Round participant. Active |
||
|
Zogenix Inc A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. |
United States | 1 Oct 2009 | Series B Initial investment. Round participant. Active |